Along with Growth Opportunities, Molecular Dx Market Likely to Bring a Wave of Consolidation | GenomeWeb

The molecular diagnostics space is likely to double to $4 billion by 2010, but the ever-increasing number of companies jumping into the space will trigger a wave of mergers and acquisitions as bigger firms swallow smaller players, according to life sciences advisory firm TSG Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.